Co-infection with hepatitis C virus (HCV) in Estonian intravenous drug users HIV epidemic
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Co-infection with hepatitis C virus (HCV) in Estonian intravenous drug users HIV epidemic ; volume:14 ; number:4 ; day:29 ; month:5 ; year:2014 ; pages:1 ; date:5.2014
BMC infectious diseases ; 14, Heft 4 (29.5.2014), 1, 5.2014
- Urheber
-
Huik, Kristi
- Beteiligte Personen und Organisationen
-
Rajasaar, Heli
Avi, Radko
Pauskar, Merit
Ustina, Valentina
Kink, Kersti
Novikova, Lilia
Maimets, Matti
Zilmer, Kai
Lutsar, Irja
SpringerLink (Online service)
- DOI
-
10.1186/1471-2334-14-S4-O18
- URN
-
urn:nbn:de:1111-2016030324065
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Huik, Kristi
- Rajasaar, Heli
- Avi, Radko
- Pauskar, Merit
- Ustina, Valentina
- Kink, Kersti
- Novikova, Lilia
- Maimets, Matti
- Zilmer, Kai
- Lutsar, Irja
- SpringerLink (Online service)
Ähnliche Objekte (12)
HIV-HCV Co-infection Among Blood Donors
No strategy to meet the HCV epidemic
Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients
HCV co-infection in HIV positive population in British Columbia, Canada
Assessment of human cytomegalovirus co-infection in Egyptian chronic HCV patients
HCV co-infection is related to acute ischemic severity and outcome
HCV monoinfection and HIV/HCV coinfection enhance T-cell immune senescence in injecting drug users early during infection
The “hidden” epidemic: a snapshot of Moroccan intravenous drug users
HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination
Increased CD56bright NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype
Differences in outpatient care and treatment utilization for patients with HIV/HCV coinfection, HIV, and HCV monoinfection, a cross-sectional study
Efficiency of HIV-1 PR-RT genotyping is not impacted by co-infection with HCV
HIV-HCV Co-infection Among Blood Donors
No strategy to meet the HCV epidemic
Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients
HCV co-infection in HIV positive population in British Columbia, Canada
Assessment of human cytomegalovirus co-infection in Egyptian chronic HCV patients
HCV co-infection is related to acute ischemic severity and outcome
HCV monoinfection and HIV/HCV coinfection enhance T-cell immune senescence in injecting drug users early during infection
The “hidden” epidemic: a snapshot of Moroccan intravenous drug users
HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination
Increased CD56bright NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype
Differences in outpatient care and treatment utilization for patients with HIV/HCV coinfection, HIV, and HCV monoinfection, a cross-sectional study
Efficiency of HIV-1 PR-RT genotyping is not impacted by co-infection with HCV
HIV-HCV Co-infection Among Blood Donors
No strategy to meet the HCV epidemic
Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients
HCV co-infection in HIV positive population in British Columbia, Canada
Assessment of human cytomegalovirus co-infection in Egyptian chronic HCV patients
HCV co-infection is related to acute ischemic severity and outcome
HCV monoinfection and HIV/HCV coinfection enhance T-cell immune senescence in injecting drug users early during infection
The “hidden” epidemic: a snapshot of Moroccan intravenous drug users
HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination
Increased CD56bright NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype
Differences in outpatient care and treatment utilization for patients with HIV/HCV coinfection, HIV, and HCV monoinfection, a cross-sectional study